A cost-effectiveness analysis for high versus standard (low) dose caffeine for the treatment of apnea in neonatal intensive care unit.
Eilan Al-HershDina AbushanabFouad AbouNahiaDaniel RainkieMoza Al HailPalli Valapila AbdulroufWessam El-KassemDaoud Al-BadriyehPublished in: Journal of pharmaceutical policy and practice (2024)
This is the first literature economic evaluation of caffeine for AOP. Despite increasing the cost of therapy, HD maintenance caffeine seems to be a cost-effective alternative to LD caffeine in Qatar. Our results support the recent global trends of increased use of HD caffeine for AOP in NICU.